Clifton Hill, Australia

Michael Quinn

This inventor holds 1 USPTO granted patent. Top assignee: Therapeuticsmd, Inc.. Active years: 2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michael Quinn. Retrieved from https://idiyas.com/inventor/michael-quinn-w89nwr87

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2016

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Michael Quinn - Innovator in Biological Sample Analysis

Introduction

Michael Quinn is a notable inventor based in Clifton Hill, Australia. He has made significant contributions to the field of biological sample analysis, particularly through his innovative methods for the depletion of high-abundance proteins. His work has implications for various applications in research and diagnostics.

Latest Patents

Michael Quinn holds a patent related to the depletion of plasma proteins. This invention focuses on methods of analysis, specifically for the preliminary fractionation of samples containing low abundance molecules of interest, such as proteins, polysaccharides, or fatty acids. The patent outlines methods for depleting high-abundance proteins from biological samples, which is crucial for enhancing the detection of low-abundance molecules. The invention also includes products and kits designed for use in these methods.

Career Highlights

Michael Quinn is associated with TherapeuticsMD, Inc., where he applies his expertise in biological analysis. His innovative approach has led to advancements in the field, making significant strides in how biological samples are processed and analyzed.

Collaborations

Michael has collaborated with notable colleagues, including Gregory E Rice and Mark S Baker. These partnerships have contributed to the development and refinement of his patented methods.

Conclusion

Michael Quinn's work in the depletion of plasma proteins represents a significant advancement in biological sample analysis. His innovative methods and collaborations continue to influence the field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…